Locations:
Search IconSearch
September 4, 2018/Neurosciences/News & Insights

Mild Head Injury in Children: Limit Imaging to High-Risk Cases

New CDC guideline issued on diagnosing and managing pediatric mTBI

How many fingers am I holding up?

Don’t rush to order a CT for a child presenting with mild traumatic brain injury (mTBI), says a new guideline released by the Centers for Disease Control and Prevention (CDC). First assess for a combination of factors indicating that the injury may be severe.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Although emergency departments and clinics see children with blows to the head on a near-daily basis, a lack of consensus on standards of care for evaluation and management have left clinicians on their own to make a host of decisions surrounding diagnosis and resumption of activities.

The CDC guideline, based on an assessment of 25 years of published evidence by a committee of experts, consists of 19 sets of clinical recommendations covering diagnosis, prognosis, management and treatment of pediatric mTBI. It appears in the current issue of JAMA Pediatrics and has been summarized in easy-to-read handouts for parents, coaches and healthcare providers on the CDC website.

“Until now, doctors, coaches and athletic trainers have had to shoot from the hip when dealing with head injury in children,” says Edward Benzel, MD, a neurosurgeon in Cleveland Clinic’s Center for Spine Health who served on the committee that developed the CDC guideline. “This new document, rigorously based on available evidence, provides objective support for common challenges.”

Key takeaways

The CDC guideline committee, including Dr. Benzel (an expert on concussion who has conducted extensive research on helmet safety), has identified the following potentially practice-changing recommendations in the new guideline:

  • Don’t routinely image patients to diagnose mTBI. Because of the small but definite risk of brain cancer from radiation, CT neuroimaging should only be used after determining clinically that the patient is at risk for a brain hemorrhage. Risk factors include age less than 2 years, vomiting, loss of consciousness, severe mechanism of injury, severe or worsening headache, amnesia, nonfrontal scalp hematoma, Glasgow Coma Scale score less than 15 and clinical suspicion for skull fracture. Note that brain MRI, single-photon emission CT (SPECT) and skull X-ray are not recommended for acute evaluation of either suspected or diagnosed mTBI.
  • Use validated age-appropriate symptom scales to evaluate mTBI. Examples include the Post-Concussion Symptom Scale, Post-Concussion Symptom Inventory and Acute Concussion Evaluation. These help determine severity and set a baseline for future monitoring and need for referral.
  • Assess evidence-based risk factors for prolonged recovery. A prior head trauma portends a poor prognosis, which is the basis for advising athletes to not be too quick to return to sports and risk another injury. Other factors associated with delayed recovery include older age (adolescents), Hispanic ethnicity, low socioeconomic status, a neurological or psychiatric disorder, low cognitive ability, and family or social stressors.
  • Counsel patients to return gradually to nonsport activities after no more than two to three days of rest. Patients and parents should be given clear verbal and written instructions on returning to full activity, including warning signs that indicate further medical care is needed. Patients should begin light activity and then gradually reintroduce regular activities that do not worsen symptoms.
  • Provide athletes with instructions on returning to sports, customized to their symptoms. Athletes should resume activities in a stepwise fashion, starting with a return to regular, nonsport activities, then light aerobic exercise, then sport-specific exercise, then noncontact training drills, then full-contact practice, and finally a full return to sport. A return of symptoms at any point should prompt going back to the previous step.
  • Know when to refer. For patients whose symptoms don’t resolve as expected after four to six weeks, refer to a neurologist or clinical psychologist familiar with head injury. Acutely worsening symptoms, chronic headache, vestibulo-ocular dysfunction, worsening sleep problems or cognitive impairment need prompt attention.

Advertisement

Thorough to the extreme

Dr. Benzel feels confident that the committee recommendations are based on thorough evaluation of the best available evidence. He notes that he reviewed about 1,000 papers related to pediatric mTBI and that others on the committee — consisting of dozens of professionals, including neurosurgeons, psychologists, emergency physicians and statisticians — carried similar workloads and engaged in lively discussion.

He identifies one particularly hot issue during the drafting of the guideline: setting the upper age limit for defining pediatric mTBI at 18. Although 18-year-olds are arguably closer to adults than children in terms of brain recovery, the committee wanted the guideline to cover all high school athletes and be easily applicable in a variety of settings.

He also notes that more work is to be done. “The final guidelines are really a call to arms to conduct better research on the issues surrounding diagnosis and management of mild TBI,” he says. “We hope to increase awareness of the importance of head injury in children and the need to quantify clinical outcomes from different scenarios.”

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad